Aigen Investment Management »

Revance Therapeutics shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $172k 20k 8.79
2023-06-30 $1.4M 54k 25.31
2023-03-31 $381k 12k 32.21
2022-12-31 $669k 36k 18.46
2021-06-30 $233k 7.9k 29.62
2020-09-30 $659k 26k 25.15
2020-06-30 $277k 11k 24.38
2020-03-31 $117k 7.9k 14.78
2019-12-31 $150k 9.2k 16.28